Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.33 USD | +3.45% | +0.24% | -18.14% |
14/06 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
14/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.14% | 3.44B | |
+15.34% | 122B | |
+20.40% | 113B | |
+8.24% | 22.84B | |
-19.79% | 20.72B | |
-16.19% | 16.51B | |
-13.58% | 16.39B | |
-44.35% | 15.83B | |
+2.75% | 13.49B | |
+66.95% | 11.67B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating